United States Hereditary Angioedema Therapeutics Market is a rare genetic disorder characterized by recurrent episodes of severe swelling in various body parts, including the limbs, face,...
Hereditary Angioedema Therapeutic Market Projected to Reach US$ 16.54 Billion by 2030, Growing at a CAGR of 16.79%
Summary: The Hereditary Angioedema Therapeutic Market is on a rapid growth traj...
“According to the research report, the global hereditary testing market was valued at USD 7.25 billion in 2023 and is expected to reach USD 13.03 billion by 2032, to grow at a CAGR of 6.80% durin...
Posted by kamal on September 15 2023 at 01:00 PM
public
The global Hereditary Testing Market size was valued at USD 11.1 billion in 2022 and is expected to reach USD 28.39 billion by 2032, exhibiting a rapid revenue CAGR of 11% during the forecast per...
